-
-
Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
-
FDA sets new record for novel device green lights in CDRH annual report
Roche’s Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Two more pharmas practice their Accent, invest in $75M series C round
Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
In The News
- Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
- UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
- Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team
Biotechnology Daily
more-
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co.…
Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
FDA sets new record for novel device green lights in CDRH annual report
Roche’s Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Approved IBS drug Bentyl may help overcome chemo-resistant prostate cancer
Market Watch
more-
Exxon Mobil Profit Declines in 1st Quarter as Natural Gas Prices Fall
Exxon Mobil’s profit declined in its first quarter as natural gas prices fell and industry…
Bio Business News
moreTwo more pharmas practice their Accent, invest in $75M series C round
Accent Therapeutics has reeled in investments from two more pharmaceutical…
Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
Sanofi has taken a surgical approach to its latest piece…
Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
Karuna Therapeutics was almost bought out by another large pharma…
World News
moreStocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
- Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
- Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
- FDA sets new record for novel device green lights in CDRH annual report
- Roche’s Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
- Two more pharmas practice their Accent, invest in $75M series C round
- Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
- Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
- Accelus accelerates expansion of spine implant tech with $20M infusion
- Exxon Mobil Profit Declines in 1st Quarter as Natural Gas Prices Fall
- Fed’s Preferred Inflation Gauge Shows Price Pressures Stayed Elevated Last Month